Scienture Holdings, Inc. Common Stock (SCNX) Stock Price

SCNXStock

$3.36−77.22%52W

Market Cap$5.52M

P/E1.33x

PEG Ratio—

Div yield—

Beta3.28

SCNX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-70.05%

Price vs S&P 500 (4W)-54.58%

VGM Score51.31

P/E Ratio (Annual)1.33x

Book Value / Share (Quarterly)$39.03

P/TBV (Annual)16.60x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-66.47%

Cash Flow / Share (Quarterly)$-8.79

Price vs S&P 500 (YTD)-85.57%

Gross Margin (TTM)97.40%

Net Profit Margin (TTM)-993.11%

EPS (TTM)$-8.63

10-Day Avg Trading Volume0.13M

EPS Excl Extra (TTM)$-8.63

Revenue Growth (5Y)-52.10%

EPS (Annual)$-67.62

Dividend / Share (Annual)$76.94

ROI (Annual)-58.46%

Gross Margin (Annual)76.80%

Net Profit Margin (5Y Avg)-656.60%

Cash / Share (Quarterly)$4.99

Revenue Growth QoQ (YoY)449.03%

P/E Normalized (Annual)1.33x

ROA (Last FY)-49.31%

Revenue Growth TTM (YoY)672.25%

EBITD / Share (TTM)$-7.88

ROE (5Y Avg)-787.09%

Operating Margin (TTM)-1053.50%

Cash Flow / Share (Annual)$-8.23

P/B Ratio0.09x

P/B Ratio (Quarterly)0.22x

Net Income / Employee (Annual)$-10,378,100

EV / Revenue (TTM)8.59x

Net Interest Coverage (TTM)-28.32x

ROA (TTM)-10.80%

EPS Incl Extra (Annual)$-67.62

Current Ratio (Annual)2.89x

Quick Ratio (Quarterly)2.83x

3-Month Avg Trading Volume0.17M

52-Week Price Return-77.22%

Revenue / Employee (TTM)$247,500

Tangible BV / Share (Quarterly)$0.27

P/S Ratio (Annual)12.79x

Asset Turnover (Annual)0.01x

52-Week High$65.00

Operating Margin (5Y Avg)-4536.17%

EPS Excl Extra (Annual)$-67.62

CapEx CAGR (5Y)99.24%

26-Week Price Return-60.14%

Quick Ratio (Annual)2.72x

13-Week Price Return-67.54%

Total Debt / Equity (Annual)0.01x

Current Ratio (Quarterly)3.04x

Enterprise Value$8.50M

Revenue / Share Growth (5Y)-53.85%

Asset Turnover (TTM)0.01x

Revenue / Employee (Annual)$107,900

Inventory Turnover (Annual)21.74x

Pretax Margin (Annual)-10080.20%

Cash / Share (Annual)$4.10

3-Month Return Std Dev92.18%

Gross Margin (5Y Avg)35.48%

Net Income / Employee (TTM)$-2,458,000

ROE (Last FY)-59.20%

Net Interest Coverage (Annual)-22.01x

EPS Basic Excl Extra (Annual)$-67.62

P/FCF (TTM)1.31x

Receivables Turnover (TTM)5.14x

Total Debt / Equity (Quarterly)0.17x

EPS Incl Extra (TTM)$-8.63

Receivables Turnover (Annual)1.16x

ROI (TTM)-12.87%

P/S Ratio (TTM)5.57x

Pretax Margin (5Y Avg)-4802.80%

Revenue / Share (Annual)$0.70

Tangible BV / Share (Annual)$7.63

Price vs S&P 500 (52W)-92.75%

Year-to-Date Return-73.65%

5-Day Price Return-14.07%

EPS Normalized (Annual)$-67.62

ROA (5Y Avg)-73.75%

Net Profit Margin (Annual)-9618.00%

Month-to-Date Return-48.23%

EBITD / Share (Annual)$-69.93

Operating Margin (Annual)-9947.06%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-143.11%

LT Debt / Equity (Quarterly)0.15x

EPS Basic Excl Extra (TTM)$-8.63

P/TBV (Quarterly)2.86x

Payout Ratio (Annual)163.90%

P/B Ratio (Annual)0.30x

Dividend / Share (TTM)$0.25

Inventory Turnover (TTM)0.62x

Pretax Margin (TTM)-993.11%

Book Value / Share (Annual)$43.14

Price vs S&P 500 (13W)-70.22%

Dividend Yield (TTM)39.64%

Beta3.28x

P/FCF (Annual)91.98x

Revenue / Share (TTM)$0.62

ROE (TTM)-13.81%

52-Week Low$3.21

vGradeB

gGradeB

mGradeF

vgmGradeC

SCNX Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 13, 2026	-$2.25	-$1.75	+22.22%(+$0.50)
Q1 2026	May 15, 2026	-$5.50	-$2.00	+63.64%(+$3.50)
Q4 2025	Mar 30, 2026	-$7.00	-$3.17	+54.68%(+$3.83)

SCNX Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.14

Industry Peers — Pharmaceuticals(574)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
SCNXScienture Holdings, Inc. Common Stock	B	B	F	5.6x	672.3%	97.4%	—	$3.36
LLYEli Lilly & Co.	D	B	A	14.9x	49.6%	83.4%	27.6%	$1257.03
JNJJohnson & Johnson	D	C	B	6.2x	7.8%	67.7%	14.9%	$255.56
ABBVABBVIE INC.	D	C	A	7.8x	10.4%	72.8%	-2.9%	$285.42
MRKMerck & Co., Inc.	D	C	A	5.4x	4.6%	77.3%	21.2%	$145.95
NVSNovartis AG	C	C	B	4.9x	3.3%	75.0%	15.3%	$150.62
AZNAstraZeneca PLC	C	B	B	4.3x	8.6%	81.3%	21.9%	$165.41
ABTAbbott Laboratories	C	C	B	3.9x	8.1%	56.8%	8.2%	$104.89
NVONovo-Nordisk A/S	B	C	C	3.5x	5.6%	80.7%	20.7%	$38.83
PFEPfizer Inc.	C	D	A	2.6x	-0.2%	74.7%	-3.5%	$29.58
VRTXVertex Pharmaceuticals Inc	D	C	B	10.1x	10.2%	86.0%	8.3%	$499.74
BMYBristol-Myers Squibb Co.	B	B	B	2.5x	3.1%	71.7%	—	$59.75
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	C	C	B	2.3x	5.0%	73.6%	-0.5%	$49.51
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	D	B	1.8x	13.4%	72.8%	-8.2%	$40.61
REGNRegeneron Pharmaceuticals Inc	C	C	A	5.2x	9.3%	86.0%	6.3%	$790.74
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	A	2.1x	3.1%	65.5%	-12.6%	$19.67
TEVATeva Pharmaceutical Industries Limited	D	C	A	2.8x	4.1%	52.9%	—	$41.50
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	6.3x	31.1%	88.5%	—	$369.06
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	A	13.8x	10.0%	—	-12.1%	$60.96
ZTSZOETIS INC.	C	C	B	3.5x	1.4%	71.6%	12.0%	$79.38
ALNYAlnylam Pharmaceuticals, Inc.	D	A	C	6.5x	95.1%	79.7%	—	$231.83
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	3215.5x	-67.6%	81.2%	—	$33.53
UTHRUnited Therapeutics Corp	C	C	B	7.2x	2.5%	86.1%	19.3%	$533.12
GMABGenmab A/S ADS	D	C	A	5.5x	22.3%	93.0%	6.8%	$37.00
VTRSViatris Inc. Common Stock	B	C	A	1.5x	4.4%	40.3%	—	$18.66
INSMInsmed, Inc.	F	A	C	18.5x	185.8%	83.5%	—	$96.27
ASNDAscendis Pharma A/S Ordinary Share	D	A	B	11.9x	113.3%	91.3%	—	$225.25
JAZZJazz Pharmaceuticals, Inc.	B	C	B	3.0x	12.6%	88.4%	-1.4%	$210.23
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	18.2x	202.4%	94.4%	—	$66.39
CORTCorcept Therapeutics Inc.	F	C	A	14.3x	16.0%	98.3%	-0.5%	$110.16
ELANElanco Animal Health Incorporated Common Stock	D	B	B	2.3x	11.9%	55.4%	29.9%	$23.55
SMMTSummit Therapeutics Inc. Common Stock	F	—	C	12187.5x	—	—	—	$14.63
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	C	B	3.1x	-0.9%	61.4%	16.5%	$13.07
BMRNBioMarin Pharmaceuticals Inc	C	C	B	3.1x	11.2%	79.6%	-17.0%	$54.68
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	8.1x	149.0%	91.5%	—	$449.74
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	213.8x	2928.4%	—	—	$84.95
CYTKCytokinetics Inc.	F	D	B	127.3x	-21.1%	—	—	$61.95
PTGXProtagonist Therapeutics, Inc	F	B	B	29.5x	34.8%	—	—	$128.75
TGTXTG Therapeutics, Inc.	D	B	B	10.3x	76.1%	82.4%	—	$53.97
AXSMAxsome Therapeutics, Inc	D	B	C	10.6x	56.9%	93.2%	—	$157.14
ARWRArrowhead Research Corporation	D	A	C	11.8x	16.9%	—	—	$55.90
ABVXAbivax SA American Depositary Shares	—	—	C	—	—	—	—	$88.13
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	5995.2x	—	—	—	$79.90
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	8.2x	-7.5%	98.2%	—	$42.94
ALKSAlkermes Inc. plc	D	C	B	4.1x	10.8%	84.6%	—	$41.22
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	789.2x	—	—	—	$241.76
AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock	D	C	A	2.0x	9.3%	39.3%	-18.4%	$19.18
KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares	D	B	A	7.3x	58.9%	89.8%	—	$78.59
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	24.7x	53.5%	70.9%	—	$86.17
LGNDLigand Pharmaceuticals Inc.	D	B	B	20.3x	54.9%	95.4%	—	$295.54
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	—	—	—	—	$142.78

About Scienture Holdings, Inc. Common Stock

Scienture Holdings Inc develops specialty pharmaceutical products and healthcare services to address unmet market needs in the United States. The company emphasizes enhancing patient engagement and streamlining the prescription experience, delivering value to patients, caregivers, and providers.